Adaptive Biotechnologies Corp (ADPT) Insider Trading
- $5,244,000.00
- $570,932,452.98
- March 24, 2025
- Chad M Robins
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 19, 2021 | CEO | 5,000 | $41.97 | Sell | $209,850.00 | |
| March 18, 2021 | SVP | 16,052 | $43.58 | Sell | $699,546.16 | |
| March 17, 2021 | CEO | 5,000 | $44.16 | Sell | $220,800.00 | |
| March 15, 2021 | Director | 4,500 | $41.75 | Sell | $187,875.00 | |
| March 15, 2021 | Insider | 1,354 | $41.69 | Sell | $56,448.26 | |
| March 10, 2021 | Director | 56,000 | $41.96 | Sell | $2,349,760.00 | |
| March 9, 2021 | CFO | 10,000 | $40.24 | Sell | $402,400.00 | |
| March 8, 2021 | Director | 500,000 | $39.50 | Sell | $19,750,000.00 | |
| Feb. 26, 2021 | President | 15,000 | $56.23 | Sell | $843,450.00 | |
| Feb. 26, 2021 | SVP | 2,812 | $55.53 | Sell | $156,150.36 | |
| Feb. 22, 2021 | President | 15,000 | $59.71 | Sell | $895,650.00 | |
| Feb. 18, 2021 | President | 15,000 | $60.92 | Sell | $913,800.00 | |
| Feb. 16, 2021 | Director | 6,000 | $65.08 | Sell | $390,480.00 | |
| Feb. 16, 2021 | SVP | 16,250 | $64.64 | Sell | $1,050,400.00 | |
| Feb. 16, 2021 | Insider | 2,000 | $65.45 | Sell | $130,900.00 | |
| Feb. 16, 2021 | President | 15,000 | $65.25 | Sell | $978,750.00 | |
| Feb. 11, 2021 | President | 15,000 | $63.28 | Sell | $949,200.00 | |
| Feb. 10, 2021 | CEO | 10,000 | $62.76 | Sell | $627,600.00 | |
| Feb. 9, 2021 | President | 15,000 | $62.41 | Sell | $936,150.00 | |
| Feb. 8, 2021 | CEO | 10,000 | $61.61 | Sell | $616,100.00 | |
| Feb. 4, 2021 | President | 15,000 | $58.98 | Sell | $884,700.00 | |
| Feb. 3, 2021 | Insider | 7,790 | $59.58 | Sell | $464,128.20 | |
| Feb. 1, 2021 | Insider | 7,790 | $55.83 | Sell | $434,915.70 | |
| Feb. 1, 2021 | President | 15,000 | $55.54 | Sell | $833,100.00 | |
| Jan. 29, 2021 | SVP | 2,813 | $56.51 | Sell | $158,962.63 | |
| Jan. 29, 2021 | President | 15,000 | $56.28 | Sell | $844,200.00 | |
| Jan. 28, 2021 | CFO | 50,000 | $56.22 | Sell | $2,811,000.00 | |
| Jan. 28, 2021 | CEO | 10,000 | $56.91 | Sell | $569,100.00 | |
| Jan. 27, 2021 | President | 15,000 | $58.94 | Sell | $884,100.00 | |
| Jan. 27, 2021 | Insider | 40,000 | $58.95 | Sell | $2,358,000.00 | |
| Jan. 26, 2021 | CEO | 10,000 | $63.53 | Sell | $635,300.00 | |
| Jan. 25, 2021 | CFO | 50,000 | $66.07 | Sell | $3,303,500.00 | |
| Jan. 25, 2021 | President | 15,000 | $66.43 | Sell | $996,450.00 | |
| Jan. 22, 2021 | President | 15,000 | $66.84 | Sell | $1,002,600.00 | |
| Jan. 21, 2021 | Insider | 23,370 | $66.82 | Sell | $1,561,583.40 | |
| Jan. 20, 2021 | President | 15,000 | $67.59 | Sell | $1,013,850.00 | |
| Jan. 19, 2021 | CEO | 8,400 | $70.43 | Sell | $591,612.00 | |
| Jan. 19, 2021 | CFO | 50,000 | $68.61 | Sell | $3,430,500.00 | |
| Jan. 19, 2021 | EVP | 25,000 | $69.00 | Sell | $1,725,000.00 | |
| Jan. 19, 2021 | Insider | 417 | $69.00 | Sell | $28,773.00 | |
| Jan. 15, 2021 | Insider | 2,000 | $66.55 | Sell | $133,100.00 | |
| Jan. 14, 2021 | President | 15,000 | $65.62 | Sell | $984,300.00 | |
| Jan. 14, 2021 | Director | 6,000 | $65.88 | Sell | $395,280.00 | |
| Jan. 12, 2021 | President | 15,000 | $62.69 | Sell | $940,350.00 | |
| Jan. 12, 2021 | CFO | 75,000 | $62.59 | Sell | $4,694,250.00 | |
| Jan. 8, 2021 | President | 8,814 | $60.46 | Sell | $532,894.44 | |
| Jan. 6, 2021 | President | 15,000 | $54.89 | Sell | $823,350.00 | |
| Jan. 4, 2021 | Insider | 6,771 | $57.39 | Sell | $388,587.69 | |
| Jan. 4, 2021 | Director | 10,000 | $57.34 | Sell | $573,400.00 | |
| Jan. 4, 2021 | President | 15,000 | $57.17 | Sell | $857,550.00 |
Insiders are both buying and selling Adaptive Biotechnologies Corp stock.
The insider traders at Adaptive Biotechnologies Corp are: Chad M Robins, Harlan S Robins, Julie Rubinstein, Chad M Cohen, Stacy L Taylor, Sharon Benzeno, R Mark Adams, Michelle Renee Griffin, Lance Baldo, Francis Lo, Nancy Louise Hill, Robert Hershberg, Eric Dobmeier, Kyle Piskel, Jyoti Palaniappan, Tycho Peterson, Nitin Sood, David E Goel, Charles Sang, Viking Global Performance Llc, Chad M. Robins, Global Investors Lp Viking, Harlan S. Robins, ADAMS R MARK, Michael J Pellini, Chad M. Cohen, Susan Bobulsky, Andris A Zoltners, and Peter M Neupert
The most active insider trader at Adaptive Biotechnologies Corp is Chad M Robins with 41 trades.
Viking Global Performance Llc has sold the most Adaptive Biotechnologies Corp stock with a total value of $245,448,434.04.
Viking Global Performance Llc has bought the most Adaptive Biotechnologies Corp stock with a total value of $10,000,000.00.
The most recent insider trade for Adaptive Biotechnologies Corp was on March 24, 2025.
The single biggest insider buy for Adaptive Biotechnologies Corp was from Viking Global Performance Llc with a total value of $5,000,000.00 on July 1, 2019.
The single biggest insider sell for Adaptive Biotechnologies Corp was from Global Investors Lp Viking with a total value of $123,800,000.00 on Nov. 11, 2020.